Status:
NOT_YET_RECRUITING
Sequential Method Determination of Oxycodone for Thoracoscope Surgery Median Effective Dose of Acute Pain Treatment
Lead Sponsor:
Jianbo Wu
Conditions:
Oxycodone
Thoracoscopic Lobectomy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to measure the median effective dose of oxycodone for the treatment of acute pain after thoracoscopic lobectomy. This clinical trial was divided into two groups base...
Eligibility Criteria
Inclusion
- The first unilateral thoracoscopic lobectomy was performed under general anesthesia
- age 18- 80 years old
- American Society of Anesthesiologists (ASA) physical status I-III
- Sign the informed consent of the patients
Exclusion
- Moderate to severe obesity (i.e., BMI \> 30kg/m2)
- Allergic or hypersensitive reaction to oxycodon
- A history of chronic pain
- Patients with significant heart, pulmonary, liver or renal disease
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06534801
Start Date
September 1 2024
End Date
April 1 2026
Last Update
August 2 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.